Skip to content

Twist Bioscience

US · TWST #1258 by market cap Listed 2018
103.32 -8.30 -7.44%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:52

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 0 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Evercore moved from Buy to Hold on 2026-07-06.

Analyst consensus 8 analysts

Buy
Avg price target 130.25 +26.1%
Price target rangecurrent 103.32
Low45.00
Avg130.25
High175.00
Buy 75% Hold 13% Sell 13%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-16 Leerink Partners -- Buy 175.00
2026-11-13 TD Cowen -- Buy 137.00
2026-11-13 CCORF -- Buy 150.00
2026-11-13 UBS -- Hold 120.00
2026-11-13 Baird -- Buy 135.00
2026-11-13 Leerink Partners -- Buy 175.00
2026-11-13 Barclays -- Buy 130.00
2026-11-12 CCORF -- Buy 150.00
2026-11-12 Guggenheim -- Buy 150.00
2026-10-13 TD Cowen -- Buy 190.00
2026-10-12 CCORF -- Buy 205.00
2026-10-07 Barclays -- Buy 215.00
2026-10-01 Guggenheim -- Buy 212.00
2026-09-29 Leerink Partners -- Buy 190.00
2026-09-18 BWS Financial -- Sell 45.00
2026-09-17 Leerink Partners -- Buy 160.00
2026-09-09 BWS Financial -- Sell 45.00
2026-08-05 Piper Sandler -- Buy 115.00
2026-08-04 Baird -- Buy 115.00
2026-08-03 TD Cowen -- Buy 115.00
2026-08-03 CCORF -- Buy 120.00
2026-08-03 William Blair -- Buy --
2026-08-03 Barclays -- Buy 112.00
2026-07-17 Leerink Partners -- Buy 110.00
2026-07-16 Leerink Partners -- Buy 110.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-07-06 Evercore Buy → Hold 102.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q4 2026-11-12 -- ±16.90% -6.83% (in line)
2026/Q3 2026-08-03 -- ±19.17% +10.39% (in line)
2026/Q2 2026-05-04 -- ±15.27% -6.97% (in line)
2026/Q1 2026-02-02 -- ±17.32% +13.98% (in line)
2025/Q4 2025-11-14 -- ±18.25% -10.13% (in line)
2025/Q3 2025-08-04 -- ±22.88% -10.30% (in line)
2025/Q2 2025-05-05 -- ±15.16% -8.44% (in line)
2025/Q1 2025-02-03 -- ±17.15% +0.73% (in line)
2024/Q4 2024-11-18 -- ±23.08% +12.31% (in line)
2024/Q3 2024-08-02 -- ±22.44% -19.00% (in line)
2024/Q2 2024-05-02 After close ±17.01% +28.74% (beat)
2024/Q1 2024-02-02 -- ±19.08% +10.01% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:52:04 · For reference only, not investment advice and not tailored to your situation.

Twist Bioscience discussion 0 comments

Add a comment